Objectives The gynaecological oncology service in Doha treats all women living in or visiting Qatar. Despite the quality and affordability of the service many women travel overseas for treatment or present following treatment overseas requesting further management. We frequently experience difficulties relating to the quality of information received regarding their management which makes follow up and ongoing treatment more challenging.

Methods Patients discussed in the multidisciplinary team meeting over a 3yr period who received treatment overseas were identified. The electronic patient record was reviewed for each patient to assess the quality of the information received regarding the clinical management (investigations, operative reports, chemotherapy and radiotherapy treatments). Pathology information received was assessed in terms of availability of reports meeting minimum dataset criteria or provision of pathological specimen blocks.

Results 15.1% of patients (n=129/850) discussed by the MDT sought treatment overseas between 4/2015 and 3/2018. Patients travelled to 28 different destinations. Most commonly U.S.A(15.7%), Philippines (15%), UK(10.5%) and Thailand(9.2%). 60% of patients provided no or poor pathology information. 19% had no formal and 29% had inadequate clinical information regarding treatment received. Only 32.6% (n=42) provided adequate clinical and pathological information.

Conclusions The quality of information provided for patients travelling between different countries frequently falls below a level that is required for confident decision making regarding future management. Development of a recommended minimum dataset report to be used for such patients would be of significant value and is perhaps something that would appropriately be managed by the IGCS.